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Abstract
AIM
To perform a meta-analysis of the association of obesity 
with hypertension and type 2 diabetes mellitus (T2DM) in 
India among adults. 
METHODS
To conduct meta-analysis, we performed comprehensive, 
electronic literature search in the PubMed, CINAHL Plus, 
and Google Scholar. We restricted the analysis to studies 
with documentation of some measure of obesity namely; 
body mass index, waist-hip ratio, waist circumference 
and diagnosis of hypertension or diagnosis of T2DM. By 
obtaining summary estimates of all included studies, the 
meta-analysis was performed using both RevMan version 
5 and “metan” command STATA version 11. Heterogeneity 
was measured by I 2 statistic. Funnel plot analysis has 
been done to assess the study publication bias.
RESULTS
Of the 956 studies screened, 18 met the eligibility criteria. 
The pooled odds ratio between obesity and hypertension 
was 3.82 (95%CI: 3.39 to 4.25). The heterogeneity 
around this estimate (I 2 statistic) was 0%, indicating low 
variability. The pooled odds ratio from the included studies 
showed a statistically significant association between 
obesity and T2DM (OR = 1.14, 95%CI: 1.04 to 1.24) with 
a high degree of variability.
CONCLUSION
Despite methodological differences, obesity showed 
significant, potentially plausible association with hyper-
tension and T2DM in studies conducted in India. Being 
a modifiable risk factor, our study informs setting policy 
priority and intervention efforts to prevent debilitating 
complications. 
Key words: Obesity; Meta-analysis; Hypertension; Type 
2 diabetes mellitus
© The Author(s) 2018. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: India with population explosion and high burden 
of non-communicable diseases (NCDs) poses a great 
challenge for the public health specialists to find the 
route cause for it. Meta-analysis to find the association 
of obesity with hypertension and type 2 diabetes mellitus 
in India proved the statistical significance association of 
obesity with major NCD’s with high degree of variability. 
Results provided with the possible risk factors for the NCD’
s and what need to be done for the preventive aspect of 
such diseases. As obesity being a risk factor, setting up 
a priority policy decisions related to interventions for the 
prevention of obesity can result in a huge dynamic change 
in the trend of NCD’s in the country like India. 
Babu GR, Murthy GVS, Ana Y, Patel P, Deepa R, Benjamin-
Neelon SE, Kinra S, Reddy KS. Association of obesity with 
hypertension and type 2 diabetes mellitus in India: A meta-
analysis of observational studies. World J Diabetes 2018; 9(1): 
40-52  Available from: URL: http://www.wjgnet.com/1948-9358/
full/v9/i1/40.htm  DOI: http://dx.doi.org/10.4239/wjd.v9.i1.40
INTRODUCTION
Indians have a higher burden of obesity and have 
relatively lower muscle mass compared to the whites[1]. 
Indians develop metabolic syndrome, hypertension, 
and type 2 diabetes mellitus (T2DM) earlier compared 
to whites, which is independent of BMI[2,3]. The available 
evidence suggests the age-adjusted prevalence of 
obesity has doubled in men and has increased three 
folds in women over two decades (1970s-1990s) in 
India[4]. Subsequent economic reforms in India (1991) 
have initiated overpowering changes in the quality and 
quantity in a number of lifestyle factors in Indians[5]. 
For example, increased consumption of unhealthy food 
and lower levels of physical activity might likely have 
contributed to an increase in the prevalence of obesity 
and its comorbidities[6].
In India, hypertension and T2DM are the major non-
communicable diseases (NCDs) leading to catastrophic 
complications including death. It is important to in-
vestigate the role of modifiable risk factors resulting 
in NCDs such as obesity, physical inactivity, tobacco 
use, and alcohol consumption[7]. Among these shared 
risk factors of NCDs, limiting the use of tobacco has 
fittingly received the greater attention of policy makers 
compared to other risk factors. However, the risk factors 
seldom act in isolation and it is important to alleviate the 
impact of their confluence. It is, therefore, important 
to determine the quantum of the risk contribution by 
individual risk factor like obesity. Available evidence 
suggests strong associations between obesity and 
NCDs[8,9]. However, none of the earlier reviews have spe-
cifically evaluated the role of obesity in the etiology of 
hypertension and T2DM in India. 
The prevalence of obesity has increased significantly 
in India over the last few decades. About a third of the 
adult population in urban India is currently estimated 
to be overweight or obese. As a result, the number of 
persons with hypertension and T2DM could increase 
exponentially[10]. Apart from contributing to T2DM 
and hypertension, obesity is a major risk factor for pul-
monary diseases, metabolic diseases, osteoarthritis, 
several cancers and serious psychiatric illness[9,11]. 
We limit our investigation to T2DM and hypertension. 
Specifically, we plan to systematically review studies 
exploring the plausible role of obesity in the etiology of 
hypertension and T2DM, synthesize the evidence, and 
perform a meta-analysis if appropriate. Understanding 
the putative role of obesity and its impact on NCDs will 
inform future interventions to reduce the burden of 
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these diseases. 
MATERIALS AND METHODS
The objective of our study is to estimate the association 
of obesity with hypertension and T2DM in Indian settings 
in adults. We developed a protocol for conducting the 
meta-analysis; with the searching strategy encompassing 
key MeSH terms, selection of article based on inclusion 
and exclusion criteria, data extraction, quality assessment 
of the study, the summary of evidence and analysis. 
Literature search and article selection 
We included only studies published in English and are 
conducted in India. We included both the original and 
review articles restricting the analysis to studies having: 
(1) documentation of some measure of obesity; AND 
(2) diagnosis of hypertension was reported; OR (3) 
T2DM was reported and diagnosed using World Health 
Organization (WHO) and American Diabetes Association 
(ADA) criteria. In addition, case-control studies must 
have compared participants with the disease (T2DM 
or hypertension) with controls without the disease. 
We excluded intervention studies, as this was beyond 
the scope of our review. We defined the exposure 
variable (obesity as adults with BMI ≥ 30 (studies 
have considered obesity as BMI with ≥ 25 and ≥ 30), 
waist circumference (WC) (≥ 80 cm for females and 
≥ 90 cm for males), and waist to hip ratio (≥ 0.80 
for females and ≥ 0.90 for males). We followed the 
Joint National Committee VII (JNC VII) criteria for the 
diagnosis of hypertension; with readings of Systolic 
Blood Pressure (SBP) ≥ 140 mmHg or Diastolic Blood 
Pressure (DBP) ≥ 90 mmHg. T2DM was diagnosed as 
per WHO and ADA classification, when Fasting Blood 
Sugar (FBS) is 126 mg/dL (≥ 7.0 mmol/L) or 2-h Post 
Prandial Blood Sugar (2 h-PPBS) is 200 mg/dL (≥ 11.1 
mmol/L)[12] (Table 1). 
We conducted a comprehensive search of all papers 
published between January 1980 and January 2016 
using MeSH terms for articles in PubMed (Table 2). We 
also screened other databases, including CINAHL Plus 
and Google Scholar for additional papers from January 
to October 2016. We contacted individual authors as 
necessary to clarify information and assess other relevant 
papers. We also reviewed cross-referenced papers cited 
in the assessed articles. 
Data extraction and analysis
Stage 1: Identification of studies for inclusion: As a 
preliminary step two authors (Yamuna Ana and R 
Deepa) independently assessed the study abstracts 
retrieved from electronic databases. 
Stage 2: Choice of valid studies: Studies selected in 
stage 1 with necessary information were independently 
assessed against the inclusion criteria. We included 
only those studies which aided in the calculation of the 
relative risk or odds ratio of exposure (obesity) and 
outcome (T2DM or hypertension).
Stage 3: Quality assessment: The primary author 
(Giridhara R Babu) developed the protocol for the 
review and monitored the overall quality of the review 
at each step. Criteria for defining obesity, T2DM, and 
hypertension were noted and crosschecked by primary 
and secondary authors (Giridhara R Babu, GVS Murthy). 
Two authors (Yamuna Ana and R Deepa) independently 
reviewed each article in its entirety for inclusion. The 
primary author (Giridhara R Babu) conducted random 
checks before data were extracted and tabulated. 
We employed the following set of criteria to evaluate 
the papers: (1) suitability of the study design; (2) 
appropriate sample size; (3) evidence regarding obesity 
and attributes of participants; and (4) accuracy of the 
tools used for quantifying obesity, diabetes and blood 
pressure. We also reviewed controlling for confounding, 
selection bias, reduction of reporting errors and stra-
tegies employed to minimize measurement bias. 
For assessing eligibility, 2 authors (Yamuna Ana and 
R Deepa) individually reviewed the full-text papers. 
Discrepancies were resolved by agreement among both 
authors which arose during the selection of articles based 
on study inclusion criteria. Disagreements regarding the 
inclusion of article were resolved by consulting Giridhara 
R Babu. If there were multiple reports related to a single 
study, we included the report with the details relevant to 
obesity and the outcome of interest. 
Stage 4: Extraction of the data and synthesis of 
results: We did a preliminary search of the electronic 
databases, after which we selected papers with a title 
and abstract that matched our criteria. We obtained 
additional articles from the references provided in the 
reviewed articles, downloaded the full texts of the article 
for review. We noted the following details; first author 
of the paper, year of publication, study design deployed, 
cut-off values for defining obesity, the prevalence of 
exposure (obesity), relative risk and odds ratio for 
T2DM and hypertension. Preferred Reporting Items 
for Systematic Reviews and Meta-Analysis (PRISMA) 
guidelines were used as the reference for assessing the 
quality of each study[13]. 
We derived the summary estimate by combining 
estimates from all the selected studies[14-24]. We did 
statistical analysis using RevMan version 5 and STATA 
version 11[25]. We used double data entry procedure and 
analysed in the Cochrane Collaboration’s Review Manager 
Software version 5 for Windows (Cochrane Collaboration, 
Oxford, England). Further, the data in the spreadsheet 
was analysed using the “metan” command of STATA 
11 version for Mac (STATA Corporation, College Station, 
Texas, United States)[25]. Crosschecking of outputs for 
internal consistency has been done and we obtained 
the pooled odds ratios reported in selected studies 
using Generic Inverse variance for overall estimates. We 
strictly conformed to the guidelines for meta-analysis of 
observational studies used in epidemiology[26]. We used 
RevMan for developing flowcharts and for examining 
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Table 1  Criteria for obesity, hypertension, and type 2 diabetes mellitus
the quality of study methodology. We calculated the 
unadjusted odds ratios with 95%CI using random-
effects model for all analyses[27]. We used funnel-plot 
analysis to assess small-study and publication bias. We 
calculated odds ratio for individual study from the data 
cell values. We calculated the pooled odds ratio using the 
individual unadjusted odds ratios of each study within 
each subgroup of case-control and cohort studies. Hence 
the pooled odds ratio was also unadjusted. We measured 
heterogeneity using I2 statistic. This describes the 
percentage of total variation across studies that is due to 
heterogeneity rather than mere chance alone producing 
this[28]. I2 can be readily calculated from basic results 
obtained from a typical meta-analysis as I2 = 100% × 
(Q - df)/Q, where Q is Cochrane’s heterogeneity statistic 
and df being the degrees of freedom. An advantage of 
I2 is that it does not depend on the number of studies 
included in the meta-analysis[29].
Risk of bias
To assess the risk of publication bias we constructed 
funnel plots for all the association between exposure 
and outcome variables.
RESULTS
Study selection
The initial search identified 6907 studies. After checking 
for duplicates, we screened 956 studies and excluded 774 
that were not relevant. Hence we included 182 studies 
for full article review and among those we excluded 164 
studies from the meta-analysis. Of these, 131 articles 
were not eligible due to non-availability of exposure or 
outcome criteria (Figure 1). The ineligible studies were 
rejected for the following reasons: Exposure criteria were 
not defined (46), obesity or overweight was not used as 
an exposure (26), studies were conducted outside India 
(21), T2DM or hypertension was not included in study 
(23) and data provided was insufficient to calculate odds 
ratio or relative risk (15). Finally, 6 studies satisfying the 
review criteria for hypertension and 12 for T2DM were 
involved in the meta-analysis. 
A descriptive overview of studies included in meta-
analysis 
One cohort study was included and rest were cross-
sectional studies. The age groups of the participants 
ranged from 20 to 55.5 years. In studies with T2DM as 
the outcome, the exposure was assessed using BMI in 5 
studies, WC in 3 studies and WHR in 4 studies. For the 
studies involving hypertension as an outcome of interest, 
five studies used BMI and one used WHR (Tables 3 and 4).
Methodological quality
Information regarding confounding factors is reported 
in all the studies and in 2 studies, the selection bias is 
Criteria for obesity, hypertension and T2DM
Obesity Hypertension (JNC VII criteria) T2DM 
BMI (≥ 30) SBP greater than or equal to 140 
mmHg or 
WHO and ADA classification: Fasting plasma glucose ≥ 7.0 mmol/L 
(126 mg/dL) or 2 h plasma glucose ≥ 11.1 mmol/L (200 mg/dL)
Waist-hip ratio (> 0.80 for females and > 0.90 
for males)
DBP greater than or equal to 90 
mmHg respectively
Waist circumference (≥ 90 cm, > 88 cm for 
female and > 102 cm for male)
DBP: Diastolic blood pressure; SBP: Systolic blood pressure; ADA: American Diabetes Association; JNC: Joint National Committee; WHO: World Health 
Organization; T2DM: Type 2 diabetes mellitus; BMI: Body mass index.
Table 2  Search terms used for literature review
Search terms for obesity and hypertension Search Terms for Obesity and type 2 diabetes
(((obesity[MeSH Terms]) AND hypertension[MeSH Terms]) AND 
prevalence[MeSH Terms]) AND India [MeSH Terms]
(((obesity[MeSH Terms]) AND type 2 diabetes[MeSH Terms]) AND 
incidence[MeSH Terms]) AND India[MeSH Terms]
(((obesity[MeSH Terms]) AND hypertension[MeSH Terms]) AND 
incidence[MeSH Terms]) AND India[MeSH Terms]
(((obesity[MeSH Terms]) AND type 2 diabetes[MeSH Terms]) AND 
prevalence[MeSH Terms]) AND India[MeSH Terms]
(((obesity[MeSH Terms]) AND hypertension[MeSH Terms]) AND relative 
risk[MeSH Terms]) AND India[MeSH Terms]
(((obesity[MeSH Terms]) AND type 2 diabetes [MeSH Terms]) AND risk 
ratio[MeSH Terms]) AND India[MeSH Terms]
(((obesity[MeSH Terms]) AND hypertension[MeSH Terms]) AND risk 
ratio[MeSH Terms]) AND India[MeSH Terms]
(((obesity[MeSH Terms]) AND type 2 diabetes[MeSH Terms]) AND relative 
risk[MeSH Terms]) AND India [MeSH Terms]
(((obesity[MeSH Terms]) AND hypertension[MeSH Terms]) AND 
attributable risk[MeSH Terms]) AND India[MeSH Terms]
(((obesity[MeSH Terms]) AND type 2 diabetes [MeSH Terms]) AND 
attributable risk[MeSH Terms]) AND India[MeSH Terms]
((((obesity[MeSH Terms]) AND hypertension[MeSH Terms]) AND 
prevalence[MeSH Terms]) OR incidence[MeSH Terms]) AND India 
[MeSH Terms]
((((obesity[MeSH Terms]) AND type 2 diabetes [MeSH Terms]) AND 
prevalence[MeSH Terms]) OR incidence[MeSH Terms]) AND India [MeSH 
Terms]
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discussed. In studies with hypertension as an outcome, 
all studies discussed measurement error vs 6 studies 
with T2DM as the outcome (Tables 3 and 4).
Publication bias
The funnel plot that depicts the publication bias sho-
wed an inverted funnel shape with studies of higher 
precision relatively closer to the pooled odds ratio. This 
corroborates minimal publication bias (Figures 2 and 3).
Combined effect of obesity and type 2 diabetes mellitus 
Odds ratio pooled from all the included studies in meta-
analysis exhibited statistically significant association 
between obesity and T2DM (OR = 1.14, 95%CI: 1.043 
to 1.237). We noticed substantial heterogeneity among 
these study estimates, with the I2 statistic being 83.9% 
and P = 0.0001. Similarly, the pooled odds ratio of 
obesity and hypertension was 3.820 (95%CI: 3.392 
to 4.248). The heterogeneity around this estimate 
(I2 statistic) was 0%, and P = 0.435 indicating low 
variability among the included studies. 
DISCUSSION
Our results show that the association between obesity 
and hypertension is strongly positive and T2DM is 
moderately positive compared with healthy non-obese 
adults in India. Through the synthesis of available 
evidence using random effects meta-analysis, we show 
that obesity in India is a formidable independent risk 
factor to mitigate; albeit the risk appears to be relatively 
less for T2DM. With industrialization and urbanization, 
the prevalence of obesity has increased gradually in 
India, heightening the need to focus on the prevention 
of these NCDs. 
Our analysis suggests that after adjustment for 
covariates, obesity is significantly associated with 
hypertension. These estimates were stable, suggested 
by low variability in the heterogeneity (I2 statistic, 0%)[30]. 
The findings concur with other studies linking body 
mass as an important risk factor to hypertension[31-33]. 
This also coincides with the observed trend of increasing 
prevalence of hypertension in India across different risk 
groups for obesity[34-37]. More specifically, the estimates 
of meta-analysis are analogous to the estimates from 
(odds ratio, 3.7; 95%CI: 2.1-6.8) synthesis of evidence 
covering 6 middle-income countries by Sanjay Basu 
et al[34], indicating increased correlation of obesity 
prevalence with hypertension across dissimilar cultures. 
The pathophysiology of developing hypertension in 
obese individuals is explained by elevated cardiac output, 
perhaps due to excess intravascular volume and reduced 
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Figure 1  Preferred reporting Items for systematic reviews and meta-analysis study flow diagram.
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cardiac contractility[38]. Recent evidence suggests 
that among obese, alteration in nutritional status, gut 
microbiota, sunlight exposure and increased physical 
activity have an important role in the presence or 
absence of hypertension[39]. Future studies may provide 
more details on these variables, including possible 
mediation. 
Our results indicate that obesity is only moderately 
associated with T2DM. Also, we observed considerable 
heterogeneity in studies involving T2DM. The results 
also indicate that this is not explained by differences 
in participant age, baseline characteristics, or study 
quality. Such heterogeneity might be seen for several 
reasons. First, the “Asian Indian Phenotype” refers to 
unique abnormalities characterized by higher chances 
of adverse effects of obesity despite lower BMI, higher 
WHR, comparatively low WC and thin stature as 
compared to other ethnic groups[40]. The lean T2DM 
is a distinct clinical entity in India. Due to temporal 
ambiguity in cross-sectional studies, it is possible that 
loss of weight might have ensued after the diagnosis 
of T2DM. In a recent survey covering eleven cities of 
India, 45% patients with diabetic retinopathy reported 
already had the visual loss when they first detected 
to have T2DM[41]. This indicates that nearly half of the 
persons with T2DM in India are undiagnosed, and 
therefore, apart from other complications would have 
lost considerable weight by the time of diagnosis. It is 
reported that nearly 53% of patients may have weight 
loss as the presenting symptom of T2DM[42]. Given 
this evidence, we estimate that nearly one-fourth of 
the undiagnosed persons with T2DM will have weight 
loss and therefore will spuriously indicate that obesity 
may not be a significant risk factor. Using cut-off points 
of BMI, WC and WHR as surrogates for percentage 
body fat in Indians, and thereby making classifications 
Table 3  Characteristics of included obesity and hypertension studies
Ref. Year Participants 
characteristics
Study characteristics Measurements Methodological quality of study
Age M (sd) in 
yr
Setting Study 
design
Sample 
size
Inclusion 
criteria
Exposure Outcome Adjusting 
confounders
Selection 
bias
Measurement 
error
Response 
rate
Reddy et 
al[14]
2003 20-30 Urban slums Cross-
sectional
1000 
(500 
male 
and 
500 
female)
Adults of 
20-60 yr 
age 
BMI > 25 Mean 
blood 
pressure 
levels
Important 
Confounders1
Not 
mentioned
Mentioned 100%
Mandal 
et al[15]
2008 40-49 Kolkata
Municipal 
Corporation
Cross-
sectional
887 Aged 20 
yr
or more
BMI ≥ 25 JNC VII
guideline
Important 
confounders1 
+ religion, 
marital status, 
nature of 
work, family 
type, animal 
protein intake
Not 
mentioned
Mentioned 
and 
discussed
98.30%
Bhadoria 
et al[16]
2014 38-50 Urban 
wards 
Cross-
sectional
939 Individuals 
aged 20 yr 
and above 
BMI ≥ 
27.5
JNC VII
guideline 
Important 
confounders1
Not 
mentioned
Mentioned 97.02%
Bhadoria 
et al[16]
2014 Males: 25-52
Female: 24-53 
48 villages 
and 15 
urban wards 
of Jabalpur 
District
Cross-
sectional
939 Aged 20 yr 
and above 
W/H 
ratio > 
0.85 for 
females 
and > 0.90 
for males
JNC VII
guideline 
Important 
confounders1
Not 
mentioned
Mentioned 97.02%
Bhadoria 
et al[16]
2014 Males: 25-52
Female: 24-53
Villages of 
Jabalpur 
district
Cross-
sectional
939 Aged 20 yr 
and above
BMI ≥ 
27.5
JNC VII
guideline
Important 
confounders1
Not 
mentioned
Mentioned 97.02%
Adhikari 
et al[17]
2015 53.9 ± 12.7 Semi-
urban in 
Mangalore 
city
cross-
sectional
800 ≥ 20 yr BMI ≥ 25 JNC VII 
criteria
 Important 
confounders1 
+ serum 
cholesterol, 
serum 
triglycerides
Mentioned 
and 
discussed
Mentioned 
and 
discussed
68.80%
1Important confounder: Age, sex, family history, history of previous events, DM, diet, smoking, alcohol, no regular exercise, saturated fat intake, excess 
salt intake, sedentary physical activity. JNC VII criteria for diagnosis: Considering JNC 7 category guideline, normal blood pressure is defined as < 120/80 
mmHg, prehypertension state is detected when systolic blood pressure (SBP) and diastolic blood pressure (DBP) is 120-139 mmHg and 80-89 mmHg 
respectively. If the blood pressure is > 140/90 mmHg it is diagnosed as hypertension with Stage 1 hypertension (when SBP and DBP are 140-159 mmHg 
and 90-99 mmHg respectively) and Stage 2 hypertension (when SBP and DBP are ≥ 160 mm Hg and ≥ 100 mmHg respectively). BMI: Body mass index; 
JNC: Joint National Committee.
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Table 4  Characteristics of included obesity and type 2 diabetes mellitus studies
Ref. Year Participants characteristics Study characteristics Measurements Methodological quality of study
Age M 
(sd) in 
yr
Setting Study 
design
Sample 
size
Inclusion 
criteria
Exposure Outcome Adjusting 
confounders
Selection 
bias
Measure-
ment error
Response 
rate
Mohan et 
al[19]
1996 55.5 ± 
11.9
Tamilnadu Cross-
sectional
1399 Individuals 
aged ≥ 20 yr
BMI ≥ 30 
kg/m2 
Diabetes 
(WHO 
criteria)
Important 
confounders1 
+, SBP, DBP
Not 
mentioned
Mentioned 
and 
discussed
90.20%
Mohan et 
al[19]
1996 55.5 ± 
11.9
Tamilnadu Cross-
sectional
1399 individuals 
aged ≥ 20 yr
WC ≥ 90 
cm 
Diabetes 
(WHO 
criteria)
Important 
confounders1 
+, SBP, DBP
Not 
mentioned
Mentioned 
and 
discussed
90.20%
Kumar et 
al[20]
Pub-
lished 
year 
2008
36.4 Kolkata Cross-
sectional 
2200 Policemen 
with (monthly 
income: 
Rs.6000-15000), 
age (20 and 60 
yr)
BMI T2DM Important 
confounders1 
+, SBP, DBP, 
Not 
mentioned
Mentioned 
and 
discussed
98.18%
Kumar et 
al[20]
Pub-
lished 
year 
2008
36.4 Kolkata Cross-
sectional 
2200 policemen 
with (monthly 
income: 
Rs.6000-15000), 
age (20 and 60 
yr)
WHR T2DM Important 
confounders1 + 
SBP, DBP
Not 
mentioned
Mentioned 
and 
discussed
98.18%
Kumar et 
al[20]
Pub-
lished 
year 
2008
36.4 Kolkata Cross-
sectional 
2200 Policemen 
with (monthly 
income: 
Rs.6000-15000), 
age: 20 and 60 
yr
WC T2DM  Important 
confounders1 
SBP, DBP
Not 
mentioned
Mentioned 
and 
discussed
98.18%
Bharati et 
al[21]
2007 20-49 Rural and 
urban field 
practice 
area.
Cross-
sectional
1370 Adults: ≥ 20 
yr
BMI > 30 T2DM 
(ADA 
classif-
ication)
Important 
confounders1 
+  blood 
cholesterol, 
hypertension
Not 
mentioned
Not 
mentioned
100%
Bharati et 
al[21]
2007 20-49 Rural and 
urban field 
practice 
area 
Cross-
sectional
1370 Adults: ≥ 20 
yr
WHR T2DM 
(ADA 
classifi-
cation)
Important 
confounders1 
+  blood 
cholesterol, 
hypertension
Not 
mentioned
Not 
mentioned
100%
Ravindra 
Singh et 
al[24]
2012-13 30-39 Agra City Cross-
sectional
633 Adults: ≥ 30 
yr residing in 
Agra City
BMI T2DM 
(WHO 
criteria)
Important 
confounders1
Not 
mentioned
Not 
mentioned
100%
Ravindra 
Singh et 
al[24]
2012-13 30-39 Agra City Cross-
sectional
633 Adults: ≥ 30 
yr residing in 
Agra City
WHR T2DM 
(WHO 
criteria)
Important 
confounders1
Not 
mentioned
Not 
mentioned
100%
Ravindra 
Singh et 
al[24]
2012-13 30-39 Agra City Cross-
sectional
633 Adults: ≥ 30 
yr residing in 
Agra City
WC (> 
88 cm for 
female 
and
> 102 cm 
for male)
T2DM 
(WHO 
criteria)
 Important 
confounders1
Not 
mentioned
Not 
mentioned
100%
Ghor-
pade et 
al[22]
2007 35-50 Rural 
Tamilnadu
Cohort 1403 Adults > 
25 yr of age 
from selected 
population
BMI ≥ 23 T2DM Important 
confounders1 + 
n work status, 
Alcohol intake
Mentioned Mentioned 
and 
discussed
85%
Vijaya-
kumar et 
al[23]
2007 30-44 Urban 
Kerala
Cross-
sectional
1990 ≥ 18 yr, 
residing since 
t 6 mo 
WHR (< 
0.80 in 
women, 
0.90 in 
men)
T2DM 
(Those 
with 
diabetes, 
and ADA 
classi-
fication)
 Important 
confounders1 
+ hyperchol-
esterolemia, 
elevated BP
Not 
mentioned
Not 
mentioned
82.70%
1Important confounders: Age, family history, sex, dietary habit, social economic status. As per WHO and ADA classification, diagnosis of diabetes is 
confirmed when fasting plasma glucose is ≥ 7 mmol/L (126 mg/dL) or 2 h plasma glucose is ≥ 11.1 mmol/L (200 mg/dL). Impaired glucose tolerance (IGT) 
test and impaired fasting glucose (IFG) test is considered as positive when the fasting plasma glucose is < 7 mmol/L (126 mg/dL) and 6.1 to 6.9 mmol/L 
(110 mg/dL to 125 mg/dL) respectively, 2 h plasma glucose is ≥ 7.8 and < 11.1 mmol/L (140 mg/dL and 200 mg/dL) and < 7.8 mmol/L (140 mg/dL) 
respectively. Both: Males and females; NA: Not available; ADA classification of diabetes: Fasting: ≥ 126 mg/dL; DBP: Diastolic blood pressure; SBP: 
Systolic blood pressure; ADA: American Diabetes Association; JNC: Joint National Committee; WHO: World Health Organization; T2DM: Type 2 diabetes 
mellitus; WC: Waist circumference; WHR: Waist to hip ratio; BMI: Body mass index.
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of obesity might have underestimated the overall 
measures[43]. The validity of universal cut-off points for 
Indians is uncertain; it would be better only to treat 
it continuous variable[8]. Future examinations should 
include analysis of the data sets from these studies for 
a continuous association. The association of obesity 
with T2DM and hypertension is highly probable at 
lower levels than the cut-off points used in this paper. 
Therefore, we might have grossly underestimated 
the association between obesity and T2DM. Further, 
Survival bias might have resulted in underestimation; 
since, people with T2DM, who are dead, debilitated, 
disabled or have severe illness might not have captured 
by the cross-sectional studies[44]. The available evidence 
concurs with our finding; while the majority of persons 
with T2DM are obese in the west, 27% of people with 
diabetes in India are lean[45-47]. These individuals may 
have different clinical and biochemical profiles, including 
predisposition to microvascular complications[46-49]. 
Such variations in phenotype used in different 
studies might include inconsistencies in specific cut-
points employed. It is also possible that most of the 
evidence from cross-sectional studies is derived from 
hospital-based populations and is, therefore, subject 
to considerable survivor bias[50]. Hence, the included 
participants in the final sample represent only survivors 
who might have had better glucose control compared 
to individuals with poor glucose control confounded by 
obesity[50]. Finally, those with T2DM may lose substantial 
amounts of weight from the disease and as a function of 
treatment[51]. Due to the cross-sectional nature of these 
studies, the temporality of obesity prior to the onset of 
T2DM cannot be established. Despite the heterogeneity, 
most estimates are in the same direction with only 2 
studies reporting less than a null association for T2DM.
The association of obesity with NCDs in India has 
several challenges. First, despite posing a major public 
health challenge, the rising prevalence of childhood 
obesity has received very little attention from policy 
makers in India. Second, compared to whites, Indians 
are more prone for obesity and decreased muscle mass 
for any proposed value of BMI[1]. With 46%[52] in the 
south and 50%[53] in the north, recent estimates suggest 
that obesity affects the unvaryingly high proportion of 
urban Indians, predisposing them to future NCDs. This 
complicates the issue since Indians within normal BMI 
can develop insulin resistance, metabolic syndrome, 
and T2DM[1]. Therefore, the severity and consequences 
of obesity might be grossly underestimated, including 
the challenge of finding an appropriate definition of 
obesity in Indians. The implications of obesity on the 
growth of the nation and future expenditures are under-
valued. Given that India is projected to have 135 million 
individuals with generalized obesity[54], around 44 
million might develop insulin resistance[55-57]. If we were 
to apply similar methodology employed by Popkin et 
al[57] in previous estimates, the annual costs attributable 
to overweight and obesity in India will surpass appro-
ximately $100 billion in 2025.
To our estimate, this is the first meta-analysis to 
summarize association of obesity with hypertension and 
T2DM in India. Our results indicate that it is important 
to consider further explorations of obesity and NCD 
associations. Intervention and policy efforts to alleviate the 
adverse effects of obesity in India, including hypertension 
and T2DM are also needed. However, there are number of 
limitations to our review. First, the possibility of conclusive 
evidence is limited due to the availability of evidence 
from cohort studies. Second, there can be considerable 
measurement issues due to heterogeneous definitions 
Study
ID Odd ratio (95%CI)
%
Weight
Reddy et al , 2005
Mandal et al , 2010
Bhadoria et al , 2014
Bhadoria et al , 2014
Adhikari et al , 2015
Bhadoria et al , 2014
Overall (I 2-squared = 0.0%, P  = 0.435)
4.10 (3.60, 4.60)
2.93 (1.97, 4.35)
7.60 (1.56, 45.25)
5.54 (0.99, 30.10)
3.12 (2.04, 4.76)
3.20 (1.70, 6.10)
3.82 (3.39, 4.25)
73.26
12.92
0.04
0.09
9.90
3.78
100.00
-45.3                       0                       45.3
Figure 2  Meta-analysis of studies exploring association between obesity and hypertension in India.
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in different population subgroups. Third, a standard 
definition of what constitutes “obesity” in Indians remains 
elusive and therefore, combining different measures 
of obesity might have led to misclassifications in this 
study. Also, in the absence of India specific cut-off points, 
inability to treat obesity as a continuous variable might 
have underestimated the association between obesity and 
T2DM. Finally, the reliance on cross-sectional studies may 
be particularly susceptible to biases, including survivor bias 
and therefore restricts causal inference.
Obesity is an important driver of NCDs in India. 
The current stage of the obesity epidemic presents an 
opportunity for policy and intervention efforts related to 
prevention. This opportunity necessitates developing a 
clear strategy for the control of NCDs through rigorous 
screening and management. The adverse effects of 
obesity cannot be assessed without robust documentation 
of obesity indicators throughout the life course. The 
increasing prevalence of obesity, hypertension, and 
diabetes in India has enormous implications for the 
healthcare system. Policymakers, Government officials, 
and public health professionals can focus policy and 
intervention efforts on obesity as an important risk factor 
to prevent NCDs like diabetes and hypertension.
ARTICLE HIGHLIGHTS
Research background
It is well known that hypertension and type 2 diabetes mellitus (T2DM) 
are the major non-communicable diseases (NCDs) leading to catastrophic 
complications and death in India. It is important to investigate the role of 
modifiable risk factors such as obesity resulting in NCDs. The authors are 
aware that the risk factors seldom act in isolation and it is important to alleviate 
the impact of their confluence. It is therefore important to determine the 
significance of risk contribution by individual risk factor like obesity. Available 
evidence suggests strong associations between obesity and NCDs. However, 
none of the earlier reviews have specifically evaluated the role of obesity in the 
etiology of hypertension and T2DM in India.
Research motivation
As obesity is one of the key NCD’s and risk factor for the majority of other NCD’s 
in India, the authors need to provide evidence to show its association with other 
major diseases like hypertension and T2DM. By exhibiting the evidence and its 
association, preventive measures can be taken for route cause of disease. 
Research objectives
To perform a meta-analysis of the association of obesity with hypertension and 
T2DM in India among adults to assess potential causal factors and improve 
prevention and control measures for these NCDs.
Research methods
The authors have followed rigorous methodology in doing comprehensive meta-
analysis with a predefined protocol. The authors entered and analysed data 
using the Cochrane Collaboration’s Review Manager software version 5 for 
Windows (Cochrane Collaboration, Oxford, England), and subsequently entered 
into a spreadsheet and re-analysed data using the “metan” command of STATA 
11 version for Mac. The authors have used the RevMan for developing flow 
chart according PRISMA guidelines, and also assessed the methodological 
quality of studies. The authors found that the pooled estimate between obesity 
and hypertension and the heterogeneity around this estimate which indicating 
low variability among the included studies. The pooled estimate from all studies 
showed a statistically significant association between obesity and T2DM. 
The authors observed considerable heterogeneity among these estimates of 
studies. 
Research results
The results shows that the association of obesity and hypertension is strongly 
positive and T2DM moderately positive compared with healthy non-obese 
Study
ID Odd ratio (95%CI)
%
Weight
Mohan et al , 2003
Kumar et al , 2008
Bharati et al , 2011
Ravindra Singh et al , 2012
Ghorpade et al , 2014
Mohan et al , 2003
Bharati et al , 2011
Kumar et al , 2008
Vijayakumar et al , 2009
Ravindra Singh et al , 2012
Kumar et al , 2008
Ravindra Singh et al , 2012
Overall (I 2-squared = 83.9%, P  = 0.0001)
-8.64                       0                       8.64
Figure 3  Meta-analysis of studies exploring association between obesity and type 2 diabetes mellitus in India.
Note: Weights are from random effects analysis
22.82
21.33
0.26
0.74
0.36
19.24
0.75
9.26
0.08
1.22
23.29
0.66
100.00
1.15 (1.12, 1.19)
0.94 (0.88, 1.01)
1.91 (0.80, 4.58)
1.40 (0.68, 2.90)
2.60 (1.40, 4.60)
1.23 (1.16, 1.35)
1.54 (0.79, 3.00)
1.42 (1.17, 1.67)
3.91 (1.77, 8.64)
1.18 (0.60, 2.31)
1.03 (1.01, 1.06)
1.87 (1.04, 3.39)
1.14 (1.04, 1.24)
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adults in India. This study provides evidence regarding the putative role of 
obesity and its impact on NCDs. This also coincides with the observed trend of 
increasing prevalence of hypertension in India across different risk groups for 
obesity.
Research conclusions
The current stage of the obesity epidemic presents an opportunity for policy 
and intervention efforts related to prevention. This opportunity necessitates 
developing a clear strategy for the control of NCDs through rigorous program 
management at national and state levels. The increasing prevalence of 
obesity, hypertension, and diabetes in India has enormous implications for 
the healthcare system. Policy makers, government officials, and public health 
professionals can focus policy and intervention efforts on obesity as an 
important risk factor to prevent NCDs like diabetes and hypertension.
Research perspectives
Study provides with experience of route cause associated with major NCD’s 
like hypertension and T2DM. As the evidence suggested obesity is associated 
with these NCD’s, it is the time to think regarding preventive aspect of obesity 
to prevent future outcome. With limited earlier statistically proved evidence, the 
current meta-analysis the association of obesity with hypertension and T2DM in 
India proved the statistical significance association of obesity with major NCD’s 
such as T2DM and hypertension with high degree of variability and substantial 
heterogeneity. Results provided the possible common risk factors for the NCD’
s and made a way for the researchers to think of the research on interventional 
measures to prevent obesity in coming future. Research involving Randomized 
Controlled Trials nested within cohort for the prevention of obesity will provide 
affirmation of fruitful interventions which can be included in future evidence 
based policy formulation.
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